BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Migueres M, Lhomme S, Izopet J. Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment. Viruses 2021;13:1900. [PMID: 34696330 DOI: 10.3390/v13101900] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Dhara AK, Nayak AK. Introduction to antiviral therapy. Viral Infections and Antiviral Therapies 2023. [DOI: 10.1016/b978-0-323-91814-5.00025-8] [Reference Citation Analysis]
2 Jung S, Lee K. Atherosclerosis by Virus Infection—A Short Review. Biomedicines 2022;10:2634. [DOI: 10.3390/biomedicines10102634] [Reference Citation Analysis]
3 Karamichali E, Foka P, Papadopoulou G, Loukaki-Gkountara D, Andresaki K, Koskinas I, Georgopoulou U. Hepatitis Viruses Control Host Immune Responses by Modifying the Exosomal Biogenesis Pathway and Cargo. Int J Mol Sci 2022;23:10862. [PMID: 36142773 DOI: 10.3390/ijms231810862] [Reference Citation Analysis]
4 Kyuregyan KK, Lopatukhina MA, Asadi Mobarkhan FA, Kichatova VS, Potemkin IA, Isaeva OV, Karlsen AA, Malinnikova EY, Kaira AN, Kozhanova TV, Manuylov VA, Mazunina EP, Bykonia EN, Kleymenov DA, Ignateva ME, Trotsenko OE, Kuznetsova AV, Saryglar AA, Oorzhak ND, Romanenko VV, Mikhailov MI. Dynamic Changes in Hepatitis A Immunity in Regions with Different Vaccination Strategies and Different Vaccination Coverage. Vaccines 2022;10:1423. [DOI: 10.3390/vaccines10091423] [Reference Citation Analysis]
5 Sarma MS, Ravindranath A. Pediatric acute viral hepatitis with atypical variants: Clinical dilemmas and natural history. World J Hepatol 2022; 14(5): 944-955 [DOI: 10.4254/wjh.v14.i5.944] [Reference Citation Analysis]
6 Sarma MS, Ravindranath A. Pediatric acute viral hepatitis with atypical variants: Clinical dilemmas and natural history. WJH 2022;14:945-56. [DOI: 10.4254/wjh.v14.i5.945] [Reference Citation Analysis]
7 Lhomme S. Special Issue "Recent Progress in Hepatitis A Virus Research". Viruses 2022;14:1138. [PMID: 35746610 DOI: 10.3390/v14061138] [Reference Citation Analysis]
8 Nain A, Kumar M, Banerjee M. Oligomers of hepatitis A virus (HAV) capsid protein VP1 generated in a heterologous expression system. Microb Cell Fact 2022;21:53. [PMID: 35392916 DOI: 10.1186/s12934-022-01780-x] [Reference Citation Analysis]
9 Liou JW, Mani H, Yen JH. Viral Hepatitis, Cholesterol Metabolism, and Cholesterol-Lowering Natural Compounds. Int J Mol Sci 2022;23:3897. [PMID: 35409259 DOI: 10.3390/ijms23073897] [Reference Citation Analysis]
10 Oliveira GCCFD, Rodrigues RN, Silva MCD, Nascimento GLMD, Lanza FM, Gusmão JD, Oliveira VCD, Guimarães EADA. Cobertura vacinal infantil de hepatite A, tríplice viral e varicela: análise de tendência temporal em Minas Gerais, Brasil. Rev bras epidemiol 2022;25:e220010. [DOI: 10.1590/1980-549720220010.2] [Reference Citation Analysis]
11 Oliveira GCCFD, Rodrigues RN, Silva MCD, Nascimento GLMD, Lanza FM, Gusmão JD, Oliveira VCD, Guimarães EADA. Childhood vaccination coverage of hepatitis A, measles, mumps and rubella, and varicella: temporal trend analysis in Minas Gerais, Brazil. Rev bras epidemiol 2022;25:e220010. [DOI: 10.1590/1980-549720220010] [Reference Citation Analysis]
12 Lee S, Lee JE, Lee SO, Sim YK, Lee SH. Ten-Year Trends of Hepatitis A Seroprevalence in People Living with HIV in Korea. Infect Chemother 2022;54:529. [DOI: 10.3947/ic.2022.0062] [Reference Citation Analysis]
13 Karabaeva VV, Krepkova LV, Babenko AN, Bortnikova VV, Fateeva TV, Mizina PG, Mikheeva NS, Karabaeva ON. Retrospective Analysis of Experimental and Clinical Studies of Flakozid in Viral Hepatitis. Razrabotka i registraciâ lekarstvennyh sredstv 2021;10:169-176. [DOI: 10.33380/2305-2066-2021-10-4-169-176] [Reference Citation Analysis]